Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease
2016 ◽
Vol 21
(5)
◽
pp. 818-824
◽
2018 ◽
Vol 12
(2)
◽
pp. 133-142
◽
Keyword(s):
2011 ◽
Vol 50
(19)
◽
pp. 2083-2088
◽
2013 ◽
Vol 29
(1)
◽
pp. 144-150
◽